
EPD · NYSE
Consensus is Hold across 16 analysts, with a mean price target of $41. The supplied consensus does not report low or high targets, so target clustering, spread, and the most- and least-bullish analysts cannot be identified. It also contains no named analyst notes or rating or target revisions during the week, making the direction of revisions unavailable. The substantive evidence around the company is operationally positive—record second-quarter results, export demand, higher margins and a $3 billion 2027 capital plan—but the supplied data do not connect those developments to individual analysts or explain why the consensus remains Hold.